Cargando…
Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma
PURPOSE: To develop a predictive model and nomogram for maculopathy occurrence at 3 years after (106)Ru/(106)Rh plaque brachytherapy in uveal melanoma. MATERIAL AND METHODS: Clinical records of patients affected by choroidal melanoma and treated with (106)Ru/(106)Rh plaque from December 2006 to Dece...
Autores principales: | Tagliaferri, Luca, Pagliara, Monica Maria, Masciocchi, Carlotta, Scupola, Andrea, Azario, Luigi, Grimaldi, Gabriela, Autorino, Rosa, Gambacorta, Maria Antonietta, Laricchiuta, Antonio, Boldrini, Luca, Valentini, Vincenzo, Blasi, Maria Antonietta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807992/ https://www.ncbi.nlm.nih.gov/pubmed/29441098 http://dx.doi.org/10.5114/jcb.2017.71795 |
Ejemplares similares
-
Personalized re-treatment strategy for uveal melanoma local recurrences after interventional radiotherapy (brachytherapy): single institution experience and systematic literature review
por: Tagliaferri, Luca, et al.
Publicado: (2019) -
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures
por: Tagliaferri, Luca, et al.
Publicado: (2017) -
Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016) -
Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
por: Cennamo, Gilda, et al.
Publicado: (2022) -
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients
por: Rossi, Ernesto, et al.
Publicado: (2023)